78 related articles for article (PubMed ID: 35805102)
21. The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression.
Tsochantaridis I; Roupas A; Mohlin S; Pappa A; Voulgaridou GP
Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676146
[TBL] [Abstract][Full Text] [Related]
22. Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.
Poturnajova M; Kozovska Z; Matuskova M
Cell Signal; 2021 Nov; 87():110120. PubMed ID: 34428540
[TBL] [Abstract][Full Text] [Related]
23. Aldehyde Dehydrogenase 1B1 Is Implicated in DNA Damage Response in Human Colorectal Adenocarcinoma.
Tsochantaridis I; Kontopoulos A; Voulgaridou GP; Tsifintaris M; Triantafyllou C; Pappa A
Cells; 2022 Jun; 11(13):. PubMed ID: 35805102
[TBL] [Abstract][Full Text] [Related]
24. Interplay between APC and ALDH1B1 in a newly developed mouse model of colorectal cancer.
Golla JP; Kandyliari A; Tan WY; Chen Y; Orlicky DJ; Thompson DC; Shah YM; Vasiliou V
Chem Biol Interact; 2020 Nov; 331():109274. PubMed ID: 33007288
[TBL] [Abstract][Full Text] [Related]
25. AMBRA1 Negatively Regulates the Function of ALDH1B1, a Cancer Stem Cell Marker, by Controlling Its Ubiquitination.
Baek SH; Jang YK
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769507
[TBL] [Abstract][Full Text] [Related]
26. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.
Chen Y; Orlicky DJ; Matsumoto A; Singh S; Thompson DC; Vasiliou V
Biochem Biophys Res Commun; 2011 Feb; 405(2):173-9. PubMed ID: 21216231
[TBL] [Abstract][Full Text] [Related]
27. Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1.
Feng Z; Hom ME; Bearrood TE; Rosenthal ZC; Fernández D; Ondrus AE; Gu Y; McCormick AK; Tomaske MG; Marshall CR; Kline T; Chen CH; Mochly-Rosen D; Kuo CJ; Chen JK
Nat Chem Biol; 2022 Oct; 18(10):1065-1075. PubMed ID: 35788181
[TBL] [Abstract][Full Text] [Related]
28. Multi-omics profiling reveals cellular pathways and functions regulated by ALDH1B1 in colon cancer cells.
Wang Y; Popovic Z; Charkoftaki G; Garcia-Milian R; Lam TT; Thompson DC; Chen Y; Vasiliou V
Chem Biol Interact; 2023 Oct; 384():110714. PubMed ID: 37716420
[TBL] [Abstract][Full Text] [Related]
29. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
30. Aldehyde dehydrogenase 1B1 is a potential marker of colorectal tumors.
Wang H; Li Y; Zhou D; Li X; Jia S; Qi S; Huang J
Histol Histopathol; 2021 Feb; 36(2):183-194. PubMed ID: 33438176
[TBL] [Abstract][Full Text] [Related]
31. Aldehyde Dehydrogenase 1B1 Is Associated with Altered Cell Morphology, Proliferation, Migration and Chemosensitivity in Human Colorectal Adenocarcinoma Cells.
Tsochantaridis I; Roupas A; Voulgaridou GP; Giatromanolaki A; Koukourakis MI; Panayiotidis MI; Pappa A
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33419031
[TBL] [Abstract][Full Text] [Related]
32. ALDH-1-positive cells exhibited a radioresistant phenotype that was enhanced with hypoxia in cervical cancer.
Yao T; Weng X; Yao Y; Huang C; Li J; Peng Y; Lin R; Lin Z
BMC Cancer; 2020 Sep; 20(1):891. PubMed ID: 32942996
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde dehydrogenase 3A1 confers oxidative stress resistance accompanied by altered DNA damage response in human corneal epithelial cells.
Voulgaridou GP; Tsochantaridis I; Tolkas C; Franco R; Giatromanolaki A; Panayiotidis MI; Pappa A
Free Radic Biol Med; 2020 Apr; 150():66-74. PubMed ID: 32006654
[TBL] [Abstract][Full Text] [Related]
34. DNA damage response and resistance of cancer stem cells.
Abad E; Graifer D; Lyakhovich A
Cancer Lett; 2020 Apr; 474():106-117. PubMed ID: 31968219
[TBL] [Abstract][Full Text] [Related]
35. Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer.
Mameishvili E; Serafimidis I; Iwaszkiewicz S; Lesche M; Reinhardt S; Bölicke N; Büttner M; Stellas D; Papadimitropoulou A; Szabolcs M; Anastassiadis K; Dahl A; Theis F; Efstratiadis A; Gavalas A
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20679-20688. PubMed ID: 31548432
[TBL] [Abstract][Full Text] [Related]
36. DNA-PK as an Emerging Therapeutic Target in Cancer.
Mohiuddin IS; Kang MH
Front Oncol; 2019; 9():635. PubMed ID: 31380275
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma.
Wang X; Yu Y; He Y; Cai Q; Gao S; Yao W; Liu Z; Tian Z; Han Q; Wang W; Sun R; Luo Y; Li C
Oncotarget; 2018 Jan; 9(2):2502-2514. PubMed ID: 29416787
[TBL] [Abstract][Full Text] [Related]
38. Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer.
Matsumoto A; Arcaroli J; Chen Y; Gasparetto M; Neumeister V; Thompson DC; Singh S; Smith C; Messersmith W; Vasiliou V
Br J Cancer; 2017 Nov; 117(10):1537-1543. PubMed ID: 28881356
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
